Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2011; 44(01): 054
DOI: 10.1055/s-0039-1699480
Commentary
Association of Plastic Surgeons of India

Is Bleomycin a worthy alternative?

Jyotsna Murthy
Department of Plastic Surgery, Sri Ramachandra Medical College and RI, Chennai, India.
› Author Affiliations
Further Information

Publication History

Publication Date:
31 December 2019 (online)

Also available at
  PDF Download Permissions and Reprints
 

  • REFERENCES

  • 1 Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg 2011;53:150-5.
  • 2 Karavelioğlu A, Temuçin CM, Tanyel FC, Ciftci AO, Senocak ME, Karnak I. Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation. J Pediatr Surg 2010;45:1627-32.
  • 3 Atwa K, Abuhasna S, Shihab Z, Hashaykeh N, Hasan R. Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation. Pediatr Pulmonol 2010;45: 192-6.
  • 4 Mulliken JB, Fischman SJ, Burrow PE. Vascular Anomalies. Curr Prob Surg 2000;37:517.
  • 5 Vargas FS, Wang NS, Lee HM, Gruer SE, Sassoon CS, Light RW. Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 1993;104:1582-4.